AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22568828
Drug: HFA-BDP (HFA-beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA-BDP (HFA-beclomethasone diproprionate 200 µg twice daily)
Trial: 20733587
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 to 100 mg, adjustable to 25 mg)
Trial: 19330598
Drug: Micronized estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Micronized estradiol (E2) 0.5 mg
Trial: 19330598
Drug: Micronized estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Micronized estradiol (E2) 1.0 mg
Trial: 9284696
Drug: Cyclical etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclical etidronate therapy (400 mg/day for 2 weeks followed by 500 mg/day elemental calcium for 11 weeks)
Trial: 8335459
Drug: Natural interferon
RxNorm normalized name: interferon beta natural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural interferon beta (5 million IU, 30-min i.v. infusion, three times weekly for 6 months)
Trial: 3594459
Drug: Oxiracetam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiracetam (2 X 800 mg, orally, bid for 8 weeks)
Trial: 21302490
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy + Smecta + Umbilical application of Lunxieting Paste (LXT) (Group C)
Trial: 21302490
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy + Smecta (Group B)
Trial: 21302490
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy only (Group A)
Trial: 17967831
Drug: Infliximab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5 mg/kg i.v. every 6 weeks)
Trial: 12562457
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei supplementation (10^8 colony-forming units/mL L. casei, thrice daily during meals for 3 weeks)
Trial: 10801757
Drug: Intracoronary gamma-radiation
RxNorm normalized name: gamma-octalactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary gamma-radiation therapy (15 Gy)
Trial: 8633574
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (660 mg/day)
Trial: 1455853
Drug: Polnitrin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polnitrin (5 mg nitroglycerin buccal tablet)
Trial: 1455853
Drug: Foreign analogue
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foreign analogue (5 mg nitroglycerin buccal tablet)
Trial: 1455853
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (0.5 mg tablet)
Trial: 3968773
Drug: Adenosine monophosphate
RxNorm normalized name: Adenosine monophosphate
DrugBank: Adenosine phosphate (DB00131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine monophosphate (AMP) treatment
Trial: 24148131
Drug: ARV initiation
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: ARV initiation after tuberculosis treatment onset
Trial: 15860983
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination of amlodipine besylate/benazepril HCl
Trial: 8979626
Drug: Enalapril monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril monotherapy
Trial: 6213250
Drug: Fenoterol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (2 mg)
Trial: 6213250
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide and fenoterol (combination)
Trial: 6213250
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide and fenoterol (both drugs)
Trial: 30762760
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) tranexamic acid (TXA) 20 mg/kg before TKA
Trial: 30762760
Drug: Intra-articular (IA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular (IA) tranexamic acid (TXA) 3.0 g after TKA
Trial: 30762760
Drug: Combined IV
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined IV (20 mg/kg) and IA (3.0 g) tranexamic acid (TXA)
Trial: 27856940
Drug: Investigational cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational cigarettes with 0.4 mg/g nicotine content
Trial: 27856940
Drug: Investigational cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational cigarettes with 0.4 mg/g high tar nicotine content
Trial: 27856940
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (15.8 mg/g nicotine content)
Trial: 19164458
Drug: FDG-PET after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDG-PET after two cycles of chemotherapy
Trial: 17556905
Drug: Indoramin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (25 mg)
Trial: 8325064
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine 0 mg
Trial: 8325064
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine 1 mg
Trial: 8325064
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine 4 mg
Trial: 8325064
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine 10 mg
Trial: 30539864
Drug: Concurrent 125I
RxNorm normalized name: fibrinogen (125I)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent 125I implantation and chemotherapy
Trial: 25027638
Drug: Protease inhibitors
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitors in HIV-positive patients with lipodystrophy syndrome
Trial: 25027638
Drug: HIV-positive patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-positive patients not using protease inhibitors
Trial: 25027638
Drug: HIV-positive patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV-positive patients treated with protease inhibitors but without posterior ankle pain
Trial: 20547525
Drug: Postpartum screening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postpartum screening for type 2 diabetes (T2DM) via oral glucose tolerance tests (OGTTs)
Trial: 18713922
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine (TDN) 30 (21 mg nicotine) patches administered 1 h before induction of anesthesia and for two additional days after surgery
Trial: 18713922
Drug: Inert (sham)
RxNorm normalized name: inert ingredients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inert (sham) patches administered 1 h before and for 2 days after surgery
Trial: 16296612
Drug: 2% SDBS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% SDBS ointment
Trial: 16296612
Drug: 2% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% metronidazole ointment
Trial: 12675669
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg diazoxide
Trial: 31770068
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine Lot 1
Trial: 31770068
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine Lot 2
Trial: 31770068
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine Lot 3
Trial: 31268126
Drug: Broccoli sprout
RxNorm normalized name: BROCCOLI SPROUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprout beverage (full dose, n=25)
Trial: 31268126
Drug: Broccoli sprout
RxNorm normalized name: BROCCOLI SPROUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprout beverage (one-half dose, n=35)
Trial: 31268126
Drug: Broccoli sprout
RxNorm normalized name: BROCCOLI SPROUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprout beverage (one-fifth dose, n=55)
Trial: 24553678
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections into the subscapularis muscle
Trial: 24553678
Drug: Scapulothoracic bursa
RxNorm normalized name: Capsella bursa-pastoris extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scapulothoracic bursa injections
Trial: 19751376
Drug: Caffeine (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (combined treatment plus prophylaxis)
Trial: 17521032
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro fine particle dose for Neohaler (NH) with 100-microg formulation
Trial: 17521032
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro fine particle dose for AeroChamber Plus (AP) with 100-microg formulation
Trial: 17521032
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro fine particle dose for Neohaler (NH) with 50-microg formulation
Trial: 17521032
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro fine particle dose for AeroChamber Plus (AP) with 50-microg formulation
Trial: 15209624
Drug: Aspirin +
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin + eradication (omeprazole 20 mg b.i.d. and amoxicillin 500 mg q.i.d. for 2 weeks)
Trial: 15209624
Drug: Aspirin +
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin + placebo eradication
Trial: 11685360
Drug: Knee splint
RxNorm normalized name: Knee Splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knee splint (special resistance-controlled knee splint for 15 min three times daily)
Trial: 7975843
Drug: Edmonston-Zagreb (EZ)
RxNorm normalized name: measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection [ProQuad]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb (EZ) virus at age 4-8 months (medium dose: 40,000 p.f.u. and high dose: 150,000 p.f.u.)
Trial: 7975843
Drug: Schwarz (SW)
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schwarz (SW) virus at age 9-12 months (standard dose: 5000 p.f.u.)
Trial: 10460069
Drug: Clomipramine 75
RxNorm normalized name: clomipramine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 75 mg/day
Trial: 800970
Drug: tolmetin (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolmetin (1600 mg/day)
Trial: 800970
Drug: phenylbutazone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: phenylbutazone (400 mg/day)
Trial: 28619301
Drug: Hydrocollator-based hot
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrocollator-based hot pack therapy (active control)
Trial: 23860345
Drug: D‐MPH‐ER 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐MPH‐ER 30 mg
Trial: 23860345
Drug: D‐MPH‐ER 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐MPH‐ER 20 mg
Trial: 21722499
Drug: Abatacept approximately
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Abatacept approximately 10 mg/kg
Trial: 19801244
Drug: Conventional irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional irrigation with NaviTip needles (20 mL NaOCl and EDTA)
Trial: 19801244
Drug: Conventional irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional irrigation with NaviTip needles + EndoActivator (20 mL NaOCl and EDTA)
Trial: 19801244
Drug: Irrigation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigation with EndoVac system (43 mL NaOCl and EDTA)
Trial: 19801244
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with saline solution (43 mL)
Trial: 10779265
Drug: High inositol
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High inositol formula (2500 micromol/L)
Trial: 10779265
Drug: Lower inositol
RxNorm normalized name: Inositol
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lower inositol formula (710 and 242 micromol/L)
Trial: 9313749
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (ultralente)
Trial: 9313749
Drug: Sulfonylurea therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea therapy (gliclazide)
Trial: 8376739
Drug: Serum vaccine
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum vaccine
Trial: 8376739
Drug: Combined regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined regimen (serum and recombinant vaccines)
Trial: 8376739
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of serum-derived vaccine
Trial: 28667207
Drug: Multidimensional intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multidimensional intervention based on individual patient-reported outcomes (PROs) including electronic assessment of PRO, creation of a case vignette, and treatment suggestions from expert panel discussions.
Trial: 28667207
Drug: Usual supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual supportive treatment.
Trial: 21735983
Drug: Knowledge of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge of soya and soya-based supplements
Trial: 21283922
Drug: Fluocinonide 0.1%
RxNorm normalized name: FLUOCINONIDE 0.1% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocinonide 0.1% cream
Trial: 19663113
Drug: Clobetasol 0.05%
RxNorm normalized name: CLOBETASOL 0.05% EMOLLIENT TOP CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobetasol 0.05% cream
Trial: 19663113
Drug: Halobetasol 0.05%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halobetasol 0.05% cream
Trial: 11245352
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose IVIG treatment
Trial: 11245352
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose MG treatment
Trial: 11245352
Drug: No IVIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No IVIG treatment (Control group)
Trial: 8181191
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ketoconazole orally once daily for 4 days
Trial: 8181191
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg itraconazole orally once daily for 4 days
Trial: 8181191
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo orally once daily for 4 days
Trial: 8181191
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg midazolam administered on day 4
Trial: 3371079
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (500 mg 3-times daily)
Trial: 3371079
Drug: Piroxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (20 mg single daily dose)
Trial: 30565543
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for dehydration, electrolyte disturbances, urinary tract infections, contusions, and bone fractures
Trial: 26525521
Drug: Ticagrelor (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (initial dose of 180 mg and maintenance dose of 90 mg twice daily, n = 149)
Trial: 26525521
Drug: Clopidogrel (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (initial dose of 300 mg and maintenance dose of 75 mg once daily, n = 151)
Trial: 23877306
Drug: Sublingual midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sublingual midazolam 0.25 mg/kg
Trial: 23877306
Drug: Sublingual dexmedetomidine
RxNorm normalized name: dexmedetomidine Sublingual Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual dexmedetomidine 1.5 µg/kg
Trial: 22275399
Drug: 30 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 μg HA 2009 H1N1 vaccine
Trial: 22275399
Drug: 15 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 μg HA 2009 H1N1 vaccine
Trial: 20737140
Drug: Oral ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibandronate (2.5 mg daily, 20 mg intermittent)
Trial: 20737140
Drug: Intravenous ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ibandronate (0.5 mg, 1 mg quarterly)
Trial: 18276620
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of NT-proBNP and E/Ea
Trial: 26376805
Drug: Imipramine (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (200-300 mg)
Trial: 10093625
Drug: Epirubicin (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (at doses equivalent to doxorubicin)
Trial: 10093625
Drug: Epirubicin (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (higher doses)
Trial: 8063233
Drug: CA 125
RxNorm normalized name: ACA 125
DrugBank: ACA 125 (DB05489)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CA 125 (> 65 U/ml)
Trial: 8063233
Drug: CA 125
RxNorm normalized name: ACA 125
DrugBank: ACA 125 (DB05489)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CA 125 (> 35 U/ml)
Trial: 8063233
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of US and CA 125 (> 65 U/ml)
Trial: 2899510
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg b.d.
Trial: 2899510
Drug: Indenolol 60
RxNorm normalized name: Indenolol
DrugBank: Indenolol (DB08952)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indenolol 60 mg o.d.
Trial: 2899510
Drug: Tyramine (i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyramine (i.v. boluses of 1-6 mg)
Trial: 20932669
Drug: Early radiotherapy
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early radiotherapy (RT) with chemotherapy (fluorouracil 375 mg/m(2)/day and leucovorin 20 mg/m(2)/day) starting on Day 1 of the first chemotherapy cycle
Trial: 20932669
Drug: Late radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Late radiotherapy (RT) with chemotherapy (fluorouracil 375 mg/m(2)/day and leucovorin 20 mg/m(2)/day) starting on Day 1 of the third chemotherapy cycle
Trial: 15311098
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (increased use of antihypertensive medications)
Trial: 18046883
Drug: Calcium-channel blockers
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-channel blockers (CCBs)
Trial: 15311098
Drug: Overall BP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall BP awareness and treatment
Trial: 9661022
Drug: ZDV (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZDV (200 mg every 8 h) alone for 4 days
Trial: 9661022
Drug: Ritonavir (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (300 mg q6h) alone for 4 days
Trial: 8151265
Drug: Metformin, 850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin, 850 mg b.i.d.
Trial: 8151265
Drug: Metoprolol CR,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR, 100 mg o.d.